Diabetic cardiomyopathy, causes and effects

被引:0
作者
Sihem Boudina
Evan Dale Abel
机构
[1] University of Utah School of Medicine,Division of Endocrinology Metabolism and Diabetes, Program in Molecular Medicine
来源
Reviews in Endocrine and Metabolic Disorders | 2010年 / 11卷
关键词
Diabetic cardiomyopathy; Diastolic dysfunction; Substrate utilization; Mitochondrial dysfunction; Uncoupling;
D O I
暂无
中图分类号
学科分类号
摘要
Diabetes is associated with increased incidence of heart failure even after controlling for coronary artery disease and hypertension. Thus, as diabetic cardiomyopathy has become an increasingly recognized entity among clinicians, a better understanding of its pathophysiology is necessary for early diagnosis and the development of treatment strategies for diabetes-associated cardiovascular dysfunction. We will review recent basic and clinical research into the manifestations and the pathophysiological mechanisms of diabetic cardiomyopathy. The discussion will be focused on the structural, functional and metabolic changes that occur in the myocardium in diabetes and how these changes may contribute to the development of diabetic cardiomyopathy in affected humans and relevant animal models.
引用
收藏
页码:31 / 39
页数:8
相关论文
共 672 条
  • [11] Aneja A(2008)Role of resistin in cardiac contractility and hypertrophy J Mol Cell Cardiol. 45 270-280
  • [12] Tang WH(2008)Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study J Am Coll Cardiol. 51 1775-1783
  • [13] Bansilal S(2003)Impact of blood pressure and insulin on the relationship between body fat and left ventricular structure Eur Heart J. 24 1500-1505
  • [14] Garcia MJ(2005)Insulin resistance and risk of congestive heart failure Jama 294 334-341
  • [15] Farkouh ME(2002)Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression J Clin Invest. 109 629-639
  • [16] Galderisi M(1977)Evidence for cardiomyopathy in familial diabetes mellitus J Clin Invest. 60 884-899
  • [17] Anderson KM(2004)Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart Faseb J. 18 1692-1700
  • [18] Wilson PW(2007)Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study Circulation 116 1170-1175
  • [19] Levy D(2008)Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus J Am Coll Cardiol. 52 1793-1799
  • [20] Devereux RB(2009)Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus Circulation 119 2069-2077